NM_020315.5:c.248A>C

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_020315.5(PDXP):​c.248A>C​(p.Glu83Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00000255 in 1,176,244 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000068 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000019 ( 0 hom. )

Consequence

PDXP
NM_020315.5 missense

Scores

1
5
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 4.97

Publications

0 publications found
Variant links:
Genes affected
PDXP (HGNC:30259): (pyridoxal phosphatase) Pyridoxal 5-prime-phosphate (PLP) is the active form of vitamin B6 that acts as a coenzyme in maintaining biochemical homeostasis. The preferred degradation route from PLP to 4-pyridoxic acid involves the dephosphorylation of PLP by PDXP (Jang et al., 2003 [PubMed 14522954]).[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDXPNM_020315.5 linkc.248A>C p.Glu83Ala missense_variant Exon 1 of 2 ENST00000215904.7 NP_064711.1 Q96GD0-1A0A024R1I3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDXPENST00000215904.7 linkc.248A>C p.Glu83Ala missense_variant Exon 1 of 2 1 NM_020315.5 ENSP00000215904.6 Q96GD0-1
ENSG00000285304ENST00000451997.6 linkc.1501+5157A>C intron_variant Intron 16 of 16 2 ENSP00000401076.2 F8WEQ3

Frequencies

GnomAD3 genomes
AF:
0.00000676
AC:
1
AN:
147952
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000151
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000194
AC:
2
AN:
1028292
Hom.:
0
Cov.:
31
AF XY:
0.00000204
AC XY:
1
AN XY:
489264
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
20300
American (AMR)
AF:
0.00
AC:
0
AN:
7578
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
11644
East Asian (EAS)
AF:
0.00
AC:
0
AN:
19818
South Asian (SAS)
AF:
0.0000784
AC:
2
AN:
25524
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
18562
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2592
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
883476
Other (OTH)
AF:
0.00
AC:
0
AN:
38798
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000676
AC:
1
AN:
147952
Hom.:
0
Cov.:
32
AF XY:
0.0000139
AC XY:
1
AN XY:
72062
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40888
American (AMR)
AF:
0.00
AC:
0
AN:
14910
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3416
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5122
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9080
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000151
AC:
1
AN:
66444
Other (OTH)
AF:
0.00
AC:
0
AN:
2040
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 14, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.248A>C (p.E83A) alteration is located in exon 1 (coding exon 1) of the PDXP gene. This alteration results from a A to C substitution at nucleotide position 248, causing the glutamic acid (E) at amino acid position 83 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.090
T
BayesDel_noAF
Benign
-0.37
CADD
Pathogenic
26
DANN
Uncertain
0.98
DEOGEN2
Benign
0.047
T
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.10
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.63
T
M_CAP
Pathogenic
0.71
D
MetaRNN
Uncertain
0.43
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L
PhyloP100
5.0
PROVEAN
Uncertain
-3.0
D
REVEL
Benign
0.17
Sift
Benign
0.10
T
Sift4G
Uncertain
0.038
D
Polyphen
0.45
P
Vest4
0.32
MutPred
0.55
Gain of MoRF binding (P = 0.0228);
MVP
0.56
MPC
2.7
ClinPred
0.75
D
GERP RS
3.9
PromoterAI
0.012
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.26
gMVP
0.63
Mutation Taster
=12/88
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1933142057; hg19: chr22-38055037; API